Urology
Royal Society of Medicine
Urothelial cancer: advances, innovation and improving outcomes
16 Apr 2027 · 8:30am to 5:00pm · Royal Society of Medicine, 1 Wimpole Street, London W1G 0AE, United Kingdom Hotels nearby
Who it’s for
Urologists, oncologists, consultants, GPs, SAS doctors and resident doctors with an interest in urological oncology.
PriceFree
up to £141
up to £141
What you learn
- Describe the key components of high-quality TURBT and their role in bladder cancer management
- Evaluate current bladder-sparing treatment options for non-muscle-invasive and muscle-invasive bladder cancer
Things to know
The fee includes
Lunch is included with non-member tickets if selected when booking; member lunch is purchased separately.
Study leave
Your trust or deanery approves study leave and funding, so ask before you book.
Every price
| Category | Price |
|---|---|
| Fee | £141 |
| Trainee | Free |
| Medical student | £44 |
Similar study days & courses.
More from RSM.
Frequently asked
- Who is Urothelial cancer: advances, innovation and improving outcomes for?
- Urologists, oncologists, consultants, GPs, SAS doctors and resident doctors with an interest in urological oncology.
- How much does Urothelial cancer: advances, innovation and improving outcomes cost?
- Fee: £141 · Trainee: Free · Medical student: £44.
Dr Robert BaxterFree–£141
BookEarly-bird ends 4 Mar 2027 · Email me before early-bird endsbooking closes 15 Apr 2027 · booking closes 16 Apr 2027
Checked against RSM’s pages · updated 20 Oct 2026